Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel target identified for long QT

Feb. 23, 2022

Sorrento's STI-9167 shows neutralizing activity against SARS-CoV-2 Omicron variants

Feb. 23, 2022

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Feb. 23, 2022

JBC-1847 proven effective against Staphylococcus aureus infection

Feb. 23, 2022

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

Feb. 23, 2022

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

Feb. 23, 2022

Phio's INTASYL-based antiviral compounds against SARS-CoV-2 enter in vivo testing

Feb. 23, 2022

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Feb. 23, 2022

Code Bio and Takeda collaborate on gene therapies for rare diseases

Feb. 23, 2022

Microlyse targets VWF and clears microvascular thrombosis

Feb. 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...